Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cyanocobalamin as Photosensitizing Agent Using to Make Cross-linking to Cornea Collagen in Treatment of Progressive Keratoconus

NCT05395650 is registered in ClinicalTrials.gov with EL Romany Ophthalmics Factory as lead sponsor.

NCT NCT05395650
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05395650 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cyanocobalamin as Photosensitizing Agent Using to Make Cross-linking to Cornea Collagen in Treatment of Progressive Keratoconus
Lead sponsor
EL Romany Ophthalmics Factory
Phase
Observational
Overall status
Unknown status
Start date
September 1, 2023
Completion date
December 1, 2023
Enrollment
1 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

keratoconus